Common Questions About Using ICD-10 Code D05.01 for Lobular carcinoma in situ of right breast
What is lobular carcinoma in situ?
Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells grow in the lobules of the breast. While it is not considered breast cancer, it indicates an increased risk for developing invasive breast cancer in the future.
How is lobular carcinoma in situ diagnosed?
LCIS is typically diagnosed through imaging studies such as mammograms and confirmed via biopsy. It is often found incidentally during evaluations for other breast conditions.
What are the treatment options for lobular carcinoma in situ?
Management of LCIS usually involves regular monitoring and surveillance rather than immediate treatment. In some cases, risk-reducing strategies, including prophylactic mastectomy, may be discussed.
Is lobular carcinoma in situ hereditary?
While LCIS itself is not hereditary, individuals with a family history of breast cancer may have a higher risk of developing both LCIS and invasive breast cancer. Genetic counseling may be recommended.
Clinical Notes
SOAP notes
DAP notes
AI medical notes